Oramed Pharmaceuticals
ORMP
#9055
Rank
C$0.17 B
Marketcap
C$4.34
Share price
3.91%
Change (1 day)
24.78%
Change (1 year)

Oramed Pharmaceuticals (ORMP) - Cash on Hand

Cash on Hand as of June 2025 : C$0.13 Billion

According to Oramed Pharmaceuticals's latest financial reports the company has C$0.13 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oramed Pharmaceuticals - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.20 B-5.24%
2023-12-31C$0.21 B1.72%
2022-12-31C$0.21 B
2021-08-31C$0.11 B128.36%
2020-08-31C$52 M20.57%
2019-08-31C$43.13 M8.36%
2018-08-31C$39.8 M58.62%
2017-08-31C$25.09 M-38.28%
2016-08-31C$40.65 M79.56%
2015-08-31C$22.64 M-2.21%
2014-08-31C$23.15 M159.75%
2013-08-31C$8.91 M76.57%
2012-08-31C$5.04 M171.99%
2011-08-31C$1.85 M45.38%
2010-08-31C$1.27 M-57.42%
2009-08-31C$2.99 M-43.79%
2008-08-31C$5.33 M163.73%
2007-08-31C$2.02 M939.9%
2006-08-31C$0.19 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ultragenyx Pharmaceutical
RARE
C$0.58 B 334.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
C$7.05 B 5,131.25%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
C$14.39 B 10,571.74%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
C$0.11 B-12.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
C$0.15 B 18.39%๐Ÿ‡บ๐Ÿ‡ธ USA